Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Feb 11;16(2):e0246525. doi: 10.1371/journal.pone.0246525

Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada

Leo Rutherford 1, Aeron Stark 1, Aidan Ablona 2,3, Benjamin J Klassen 3, Robert Higgins 1, Hanna Jacobsen 1,3, Christopher J Draenos 3, Kiffer G Card 1,3, Nathan J Lachowsky 1,3,*
Editor: H Jonathon Rendina4
PMCID: PMC7877578  PMID: 33571252

Abstract

There is a paucity of population health data on the experiences of transgender, non-binary, and other gender minority gay, bisexual, and queer men, and Two-Spirit people in Canada. To address this gap, this article presents a socio-demographic and health profile of trans and non-binary participants from the community-based bilingual 2018 Sex Now Survey. Participants were recruited in-person from Pride festivals in 15 communities to self-complete an anonymous paper-and-pen questionnaire. To be eligible, participants needed to be at least 15 years old, live in Canada, either report a non-heterosexual sexual identity or report sex with a man in the past 5 years, and not report gender identity as a woman. Through community consultations the survey was inclusive of trans men, non-binary people, and Two-Spirit people. Three gender groups (cisgender, transgender, and non-binary) were created, and trans and non-binary participants were compared with their cisgender peers across a variety of demographic, mental health, sexual health, and general health indicators. Odds ratios were calculated to determine initial significance for categorical variables, and adjusted odds ratios were calculated to control for five possible confounders (age, ethnoracial identity, country of birth, sexual identity, and financial strain). Significant differences emerged across all sets of indicators, with many of these findings remaining significant after adjusting for confounding variables, including significantly higher reported rates of mental health challenges and sexual health service barriers for trans and non-binary participants compared to the cisgender group. Trans and non-binary participants were also more likely to be in polyamorous relationships. Collectively, our findings demonstrate that trans and non-binary people experience significant disadvantages compared with cisgender sexual minority men. Improved educational supports and employment protections, access to queer and gender affirming healthcare, and trauma-informed mental health services are needed to improve the health wellbeing of trans and non-binary people in Canada.

Introduction

A robust body of evidence demonstrates that gay, bisexual, queer and other sexual minority men in Canada face a greater burden of health inequities–for example, in relation to mental health and HIV transmission–when compared with their heterosexual peers. However, there is a paucity of data on the health experiences of trans, non-binary, and other gender minority people in Canada. Indeed, very little population health research has been conducted with trans, non-binary, and Two-Spirit people in Canada. Notable exceptions include the 2010 Trans PULSE study of trans people in Ontario, which included both quantitative and qualitative data collection [13], the Canadian Trans and Non-binary Youth Health Survey [4], and the recent national Trans PULSE Survey, for which data analysis and reporting is ongoing [5].

Existing evidence indicates that there are significant socioeconomic and healthcare disparities between trans and non-binary people and their cisgender peers, such as barriers to accessing healthcare. For example, findings from Sex Now 2015, a national health and wellbeing survey of gay, bisexual, and queer men and non-binary and Two-Spirit people (GBT2Q) in Canada, indicate that trans GBT2Q participants were significantly more likely to report experiencing healthcare discrimination in their lifetime and in the past 12 months when compared with cisgender GBT2Q participants [6]. While not solely focused on GBT2Q men, the national and Ontario (Canada’s most populous province) Trans PULSE studies have found similar healthcare access challenges. The Trans Pulse Canada Team found that 45% of respondents reported one or more unmet healthcare needs in the past year and 12% had avoided the emergency room in the past year [5]. The Ontario-based Trans PULSE study found negative experiences with healthcare providers among trans individuals, as 52% of respondents who presented in their felt gender reported having experienced transphobia in the emergency room [1]. Bauer et al. estimate that 38% of trans people in Ontario had prior trans-specific negative experiences with family physicians, and approximately half were uncomfortable discussing trans issues with their doctor [2]. These statistics highlight that barriers to acceptable healthcare persist for many trans and non-binary people.

Additionally, trans and non-binary people often report healthcare disparities, and poorer physical and mental health than their cisgender peers [5, 6]. Trans PULSE Canada respondents tended to rate their general health better than their mental health, as 73% of respondents indicated their health was good, very good, or excellent, but only 44% reported the same about their mental health [5]. Indeed, 31% had considered suicide and 6% had attempted suicide in the past year. The 2019 Canadian Trans and Non-binary Youth Health Survey found even more concerning levels of poor mental health, with only 16% of respondents reporting their mental health as good or excellent [4]. Most youth (88%) reported having a chronic mental health condition, such as depression or anxiety. Within the past year alone, 64% of youth had considered suicide and 21% had attempted suicide [4]. Collectively, these data indicate that there are heightened mental health challenges for young trans people compared with the general trans population.

Regarding sexual health, existing Canadian data indicates that trans men are less likely to report condomless sex and sex with casual partners, which suggests lower prevalence of sexual encounters that might lead to HIV transmission [6, 7]. Trans PULSE found that only 7% of GBT2Q transmasculine participants had had a high-risk sexual experience in the past year, and 25% had not had a sex partner at all in the past year [7]. All HIV-related risk was associated with the subgroup of participants who had cisgender men as sex partners, but only one-third of participants fell into this category, making the remaining two-thirds categorically low-risk. While these behaviour profiles suggest a general low HIV risk, existing evidence also indicates that trans men test less frequently for HIV and STIs, while also highlighting several barriers to testing for trans men [68]. Qualitative interviews by Rich et al. with gay, bisexual and queer transgender men in Vancouver, BC illuminated several possible explanations for these findings. Some of these Vancouver participants were living in an urban centre and well-connected to healthcare systems, such as routine transition-related care appointments that made integrating HIV testing into their regular healthcare regimen easy [9]. However, other participants also described barriers to HIV testing and accessing healthcare in general, such as a lack of trans competency in care providers and past experiences of healthcare discrimination. Both Scheim et al. and Rich et al. argue that trans men are often excluded from existing health services and campaigns, and trans-competent sexual healthcare should be integrated into services targeted at both the general population and at sexual minority men [7, 9].

Experiences of discrimination, marginalization, and oppression for trans and non-binary people are also observable in socioeconomic indicators [10]. Despite being a highly educated population, with 89% of Trans PULSE Canada respondents aged 25 and older having at least some post-secondary education, trans and non-binary people face high rates of poverty and homelessness. The National Trans PULSE survey found that half of respondents 25 years of age or older had a personal income of less than $30,000/year, and 40% lived in a low-income household [5]. Furthermore, 10% of respondents were currently housing insecure (including homeless or living in temporary and unstable housing) and 15% responded their household sometimes or often did not have enough to eat in the last 12 months [5].

Despite the many manifestations of oppression and marginalization in trans people’s lives, research suggests that some of these impacts may be mitigated by positive factors such as trans-affirming social support and connection. Veale et al.’s research on trans and non-binary youth between the ages of 14 and 25 in Canada found that enacted stigma, as measured through experiences of harassment, discrimination, bullying, and physical and sexual violence, was associated with higher likelihood of negative mental health outcomes, such as non-suicidal self-injury, recent suicide attempt, and extreme stress and despair [11]. However, supportive environments and social connections with family, friends, and school reduced the negative effects of enacted stigma on trans youth’s mental health [11]. Similarly, the Trans PULSE Ontario project found that several structural and interpersonal factors had a strong impact on suicide ideation or attempts for trans individuals. Their modelling found that factors such as fewer experiences of transphobic discrimination and violence, strong parental support for gender identity or expression, having an identity document with a gender marker that matched one’s lived gender, and having completed medical transition when it was desired were all associated with a reduced likelihood of suicidal ideation and attempts [12].

The limited data available suggests that trans and non-binary people in Canada experience discrimination, oppression and marginalization that results in barriers in accessing healthcare, experiences of verbal, physical, and sexual violence, poverty, physical and mental illness, and a variety of other negative socioeconomic and health indicators. To further substantiate this area of inquiry, this article presents a socio-demographic and health profile of trans and non-binary participants from a community-based population health data source, the 2018 Sex Now Survey, which provides valuable information for guiding interventions to address inequities among trans and non-binary communities.

Methods

Sex Now is a national periodic cross-sectional survey conducted by the Community-Based Research Centre (CBRC) to promote the health and well-being of GBT2Q people. It is Canada’s largest and longest running survey of GBT2Q health and well-being, providing an essential source of data that is widely used by community, public health, research, and policy stakeholders. The survey was originally commissioned in 2002 by the BC Centre for Disease Control (CDC) as an investigation into rising HIV infection rates among gay men in the province of British Columbia. Since then, there have been several survey cycles starting with BC Pride Festivals in 2002 & 2004, moving to the internet in 2006, 2007 & 2008, and then to cover all of Canada in 2010, 2012, 2015, and 2018.

For Sex Now 2018, we consulted with community organizations and stakeholders across the country to develop the survey. This included targeted consultation with trans men, non-binary people, and Indigenous Two-Spirit community members. Subsequently, many of these community organizations led in-person recruitment at Pride festivals and related events across 15 Canadian cities between May and September 2018. Recruitment cities (from west to east) included Vancouver, New Westminster, Surrey, Abbotsford, Kamloops, Kelowna, Calgary, Edmonton, Winnipeg, London, Toronto, Ottawa, Cornwall, Montreal, and Halifax. Community partners provided staff and volunteers for specific sites and oversaw the administration of the self-completed anonymous paper-and-pen surveys. Community partners also promoted the survey in advance of these events through their social media and listservs; additional online promotion was also done by CBRC. Past versions of the survey have been instrumental in supporting GBT2Q health groups to better support their programs, secure funding, and advocate for policy change. The current questionnaire is freely available on the CBRC website, and includes sections on demographics, sex life, sexual health, blood donation, HIV and Hepatitis C, mental health, substance use, social health, healthcare, discrimination, and violence. Participants were asked four questions about how often they had been bothered by different symptoms of depression and anxiety over the last two weeks. The first two questions (“Little interest or pleasure in doing things” and “Feeling down, depressed, or hopeless”) were taken from the Patient Health Questionnaire-2 (PHQ-2) [13] to assess for depressive symptoms. Questions three and four (“Feeling nervous, anxious or on edge” and “Not being able to stop or control worrying”) were taken from the Generalized Anxiety Disorder-2 (GAD-2) [14] to assess symptoms of anxiety. Response options were “not at all,” “several days,” “more than half the days,” and “nearly every day.” From these questions, two mental health measures were established: one for depression and one for anxiety. For each measure, the possible range of scores was 0 through 6, with a score of 0 indicating a respondent answered “not at all” to both questions, and a score of 6 meaning the person answered “nearly every day” to both questions. A score of 3 could mean that a participant had either experienced one symptom “nearly every day” or selected “more than half the days” as one response and “several days” as the other response. A cut-off of 3 or higher is indicative of a possible depression or anxiety disorder, and was chosen by the developers of these measures to determine if further evaluation is necessary. For both depression and anxiety, a binary variable was created using the cut-off value of 3 (the standard cut-off point for these measures). All questions in the survey were optional and some participants elected not to respond to some questions.

Funding for the Sex Now 2018 survey cycle was provided by Canadian Blood Services (CBS) to generate evidence on potential policy alternatives to blood donor deferral for “men who have sex with men.” At the time of survey administration, trans blood donors were screened based on their sex assigned at birth, unless they had had any lower gender affirming genital surgery procedure(s), previously referred to as sex reassignment. We recognize that these risk assessment policies are cisnormative, do not affirm the identities of trans and non-binary people, and do not attend to the complexity of trans and non-binary bodies.

In order to be eligible for Sex Now 2018, participants had to: 1) self-identify as men (inclusive of people reporting trans experience), non-binary (regardless of sex assigned at birth), or Two-Spirit; 2) identify as gay, bisexual, queer, or another non-heterosexual identity and/or have reported having had sex with another man (cis or trans) in the last 5 years; 3) be 15 years of age or older; 4) be living in Canada; 5) be able to provide informed consent and complete the questionnaire in either French or English, and; 6) must not have already participated in the study at another venue. The ethics protocol for this study was reviewed and approved by the research ethics boards at the University of Victoria (BC17-487), University of British Columbia (BC17-487), and University of Toronto (35929). Oral consent was obtained from all study participants. No parental consent was required from parents or guardians of minors, our REB approved individual assent for participants aged 15 and older. Participants were given Sex Now-branded dog tags as a as a token of appreciation for participating in the study.

This paper analyzes Sex Now 2018 socio-demographic and health and well-being data to highlight salient similarities and differences across three overarching gender history and identity groups: cisgender, transgender, and non-binary. Participants were grouped into these categories based on their responses to two survey questions: gender identity and transgender lived experience. The first question, “What is your gender identity?,” had three options: “man,” “woman,” and “neither. I prefer to self-describe as: _____________.” A participant could only select one answer as a response. As per above, participants were eligible if they answered “man” or “neither;” those who answered “neither” had an opportunity to provide a written response for how they self-describe their gender identity. The second question asked was, “Do you have trans experience? (i.e., your gender is different than the sex you were assigned at birth).” A participant could answer either “yes” or “no.” In order to be included in this report’s analysis, participants had to answer both of these questions. Using these two questions, we created three participant groups. The cisgender group is composed of all participants that selected “man” as their gender identity and responded “no” to the question about trans experience. The transgender group includes all participants who selected “yes” to trans experience, regardless of their gender identity being man or non-binary. We defined the non-binary group as those who responded “neither” man nor woman to the question of gender identity, irrespective of their trans experience. This included a variety of identities including those who wrote in responses such as ‘genderqueer’ or ‘enby,’ who were all categorized as non-binary for this study. Therefore, the trans and non-binary groups are not mutually exclusive. This means that some trans participants are also included in the non-binary group and vice versa.

The survey data were analyzed using Statistical Package for the Social Sciences (SPSS) version 26 for Mac. The cisgender group was compared with both the trans and the non-binary group. A statistical comparison of the trans group with the non-binary group was not possible due to the overlap of participants across these two groups (i.e., these groups are not mutually exclusive). However, although statistical comparisons were not possible, we include some descriptive comparisons of the two groups. Odds ratios were calculated to determine initial statistically significant differences between trans versus cisgender and non-binary versus cisgender groups. Univariate and multivariate logistic regression models were used to quantify the relationship between trans participants (versus cisgender) and non-binary participants (versus cisgender) across multiple health domains. All models were adjusted for five confounders: age, white ethnoracial identity vs. non-white ethnoracial identity, born in Canada vs. not, gay sexual identity vs. not, and financial strain. Each variable reported on in the results section was assessed in a separate model and adjusted for the same five confounders. Odds ratios and 95% confidence intervals (95%CI) are reported, with interpretation of significant relationships where 95%CIs do not include 1. As these statistical tests assume that data were collected through random probability sampling, results should be taken with caution as they may be biased by the fact that respondents are not representative of the broader population.

Results

There was a final analytic sample of 3,083 cisgender participants, 296 trans participants, and 150 non-binary participants, with 106 participants who identified both as non-binary and as having trans experience.

Recruitment site & demographics

City of recruitment differed between trans and cisgender participants in notable ways (Table 1). A higher percentage of trans respondents participated in the smaller cities of Halifax, London, and the interior of British Columbia (Kelowna and Kamloops) compared with cisgender participants, while Ottawa had a smaller percentage of trans respondents participate. When odds ratios were calculated, the only statistically significant difference was that more trans participants were recruited in London compared with other cities. There was no statistically significant difference in city of recruitment between non-binary and cisgender participants.

Table 1. City of recruitment and demographic factors among cisgender, trans, and non-binary participants.

Overall Cisgender Trans Non-Binary
City of Recruitment n % n % n % OR n % OR
Calgary 265 7.5% 236 7.7% 26 8.8% Ref 10 6.7% Ref
Edmonton 297 8.4% 263 8.5% 19 6.4% 0.66 (0.35–1.21) 15 10.0% 1.35 (0.60–3.15)
Halifax 199 5.6% 164 5.3% 27 9.1% 1.45 (0.84–2.66) 8 5.3% 1.15 (0.43–2.98)
Kamloops and Kelowna 121 3.4% 101 3.3% 18 6.1% 1.62 (0.84–3.07) 10 6.7% 2.34 (0.93–5.86)
London 154 4.4% 115 3.7% 30 10.1% 2.37 (1.34–4.21) 11 7.3% 2.26 (0.93–5.57)
Montreal 418 11.9% 351 11.4% 26 8.8% 0.67 (0.38–1.19) 21 14.0% 1.41 (0.67–3.18)
Ottawa 411 11.7% 371 12.0% 24 8.1% 0.59 (0.33–1.05) 11 7.3% 0.70 (0.29–1.70)
Toronto 806 22.9% 716 23.2% 58 19.6% 0.74 (0.46–1.21) 33 22.0% 1.09 (0.55–2.36)
Vancouver 672 19.1% 606 19.7% 52 17.6% 0.78 (0.48–1.29) 23 15.3% 0.90 (0.43–2.00)
Winnipeg 181 5.1% 160 5.2% 16 5.4% 0.91 (0.46–1.73) 8 5.3% 1.18 (0.44–3.06)
Age Group
<25 706 20.0% 555 18.0% 125 42.2% Ref 61 40.7% Ref
25–29 720 20.4% 644 20.9% 53 17.9% 0.37 (0.26–0.51) 38 25.3% 0.54 (0.35–0.81)
30–39 973 27.6% 883 28.6% 59 19.9% 0.30 (0.21–0.41) 28 18.7% 0.29 (0.18–0.45)
40–49 421 11.9% 380 12.3% 26 8.8% 0.30 (0.19–0.47) 11 7.3% 0.26 (0.13–0.49)
50–59 437 12.4% 399 12.9% 21 7.1% 0.23 (0.14–0.67) 5 3.3% 0.11 (0.04–0.26)
60+ 230 6.5% 206 6.7% 9 3.0% 0.19 (0.09–0.37) 5 3.3% 0.22 (0.08–0.51)
Ethnoracial Identity (ref: no)
African, Caribbean, Black 145 4.1% 124 4.0% 14 4.7% 1.18 (0.64–2.02) 11 7.3% 1.89 (0.94–3.43)
Arab, West Asian (e.g. Iranian, Afghan) 116 3.3% 101 3.3% 8 2.7% 0.82 (0.36–1.60) 8 5.3% 1.66 (0.73–3.28)
East or Southeast Asian (e.g. Chinese, Japanese, Korean) 298 8.5% 274 8.9% 15 5.1% 0.55 (0.31–0.90) 10 6.7% 0.73 (0.36–1.34)
Indigenous 314 8.9% 250 8.1% 49 16.6% 2.25 (1.60–3.11) 24 16.0% 0.73 (0.36–1.34)
Latin American, Hispanic 180 5.1% 159 5.2% 13 4.4% 0.84 (0.45–1.45) 7 4.7% 2.16 (1.34–3.34)
South Asian (e.g. East Indian, Pakistani, Sri Lankan) 113 3.2% 89 2.9% 14 4.7% 1.67 (0.90–2.88) 7 4.7% 0.90 (0.38–1.82)
White 2594 73.6% 2271 73.7% 227 76.7% 1.18 (0.89–1.57) 105 70.0% 0.83 (0.59–1.20)
Other 33 0.9% 27 0.9% 5 1.7% 1.94 (0.66–4.68) 4 2.7% 3.10 (0.91–8.06)
Born in Canada
No 883 25.1% 799 25.9% 52 17.6% Ref 30 20.0% Ref
Yes 2583 73.3% 2245 72.8% 239 80.7% 1.64 (1.21–2.25) 115 76.7% 1.36 (0.92–2.09)
Sexual Identity (ref: no)
Gay 2816 79.9% 2627 85.2% 108 36.5% 0.10 (0.07–0.12) 49 32.7% 0.08 (0.06–0.12)
Asexual 33 0.9% 19 0.6% 11 3.7% 6.22 (2.84–13.00) 7 4.7% 8.00 (3.08–18.55)
Straight 27 0.8% 20 0.6% 5 1.7% 2.63 (0.87–6.55) 1 0.7% 1.04 (0.06–5.05)
Bisexual 426 12.1% 320 10.4% 80 27.0% 3.20 (2.40–4.23) 26 17.3% 1.84 (1.16–2.81)
Pansexual 178 5.1% 87 2.8% 81 27.4% 13.00 (9.31–18.14) 48 32.0% 16.57 (11.01–24.79)
Queer 330 9.4% 204 6.6% 100 33.8% 7.22 (5.44–9.54) 74 49.3% 14.19 (9.97–20.23)
Heteroflexible 27 0.8% 17 0.6% 7 2.4% 4.37 (1.68–10.21) 2 1.3% 2.47 (0.39–8.72)
Other 21 0.6% 13 0.4% 7 2.4% 5.72 (2.13–14.08) 4 2.7% 6.47 (1.81–18.54)
Financial Strain
Comfortable, with extra 1364 38.7% 1264 41.0% 57 19.3% 0.14 (0.09–0.21) 31 20.7% 0.13 (0.07–0.21)
Enough, but no extra 1411 40.0% 1244 40.4% 118 39.9% 0.29 (0.20–0.42) 53 35.3% 0.22 (0.14–0.36)
Have to cut back 472 13.4% 390 12.7% 68 23.0% 0.54 (0.36–0.81) 32 21.3% 0.42 (0.25–0.72)
Cannot make ends meet 235 6.7% 160 5.2% 52 17.6% Ref 31 20.7% Ref

There were statistically significant differences in the age profiles of trans and non-binary participants when compared with cisgender participants (Table 1). Both trans and non-binary groups were younger than the cisgender group; the proportions of both trans and non-binary participants under the age of 25 was more than double the proportion of cisgender participants under the age of 25. Compared with cisgender participants, trans participants were more likely to be under the age of 25 (42.2% vs. 18.0%) and less likely to be aged 30–39 (19.9% vs. 28.6%), 50–59 (7.1% vs. 12.9%), and over 60 (3.0% vs. 6.5%). Among non-binary respondents, two-thirds (66.0%) were under the age of 30. Compared with cisgender participants, non-binary participants were more likely to be under the age of 25 (40.7% vs. 18.0%) and less likely to be aged 30–39 (18.7% vs. 28.6%) or 50–59 (3.3% vs. 12.9%). For both trans and non-binary groups, calculated odds ratios indicated statistically significant differences across all age categories when compared with cisgender participants.

Ethnoracial identities were not mutually exclusive as participants could identify with multiple groups (Table 1). Compared with cisgender participants (8.9%), a lower percentage of trans participants identified as East or Southeast Asian (5.1%). The percentage of trans participants identifying as Indigenous was twice that of the cisgender sample (16.6% vs. 8.1%). Compared with cisgender participants, non-binary participants were more likely to identify as African, Caribbean or Black (7.3% vs. 4.0%), Indigenous (16.0% vs. 8.1%), or “other” (2.7% vs. 0.9%).

A statistically significant difference existed between the proportion of cisgender and trans participants who were born in Canada (Table 1), with trans participants being more likely to be born in Canada than cisgender participants (80.7% vs. 72.8%). There was no statistically significant difference between the proportion of cisgender and non-binary participants born in Canada. Approximately 1 in 5 trans and non-binary participants were born in a country other than Canada.

Participants were able to select more than one sexual identity (i.e., selections were not mutually exclusive). There was a larger variation in sexual identities among trans and non-binary participants compared with cisgender participants (Table 1). Most cisgender participants identified as gay (85.2%) and/or bisexual (10.4%). More than one-third of trans respondents identified as gay (36.5%) and as queer (33.8%), and more than one-quarter as pansexual (27.4%) and as bisexual (27.0%). Compared with cisgender participants, trans participants were significantly less likely to identify as gay (36.5% vs. 85.2%), but significantly more likely to identify as queer (33.8% vs. 6.6%), pansexual (27.4% vs. 2.8%), bisexual (27.0% vs. 10.4%), asexual (3.7% vs. 0.6%), heteroflexible (2.4% vs. 0.6%), and other (2.4% vs. 0.4%). Half of non-binary participants identified as queer (49.3%), and one-third as gay (32.7%) and as pansexual (32.0%). Compared with cisgender participants, non-binary participants were significantly less likely to identify as gay (32.7% vs. 85.2%), but significantly more likely to identify as queer (49.3% vs. 6.6%), pansexual (32.0% vs. 2.8%), bisexual (17.3% vs. 10.4%), asexual (4.7% vs. 0.6%), and other (2.7% vs. 0.4%). Non-binary participants were just as likely to identify as straight compared with cisgender participants (0.7% and 0.6% respectively).

Participants were asked to self-rate their money situation at one of four levels shown in the table below (Table 1). Overall, cisgender participants reported less financial strain than both trans and non-binary participants. More than 4 in 5 (81.4%) cisgender participants reported having enough money at the time of survey. Compared with cisgender participants, trans participants were approximately half as likely to report their money situation as “comfortable, with extra” (19.3% vs. 41.0%), almost twice as likely to report having to cut back (23.0% vs. 12.7%), and more than three times as likely to not be able to make ends meet (17.6% vs 5.2%). Compared with cisgender participants, non-binary participants were approximately half as likely to report their money situation as “comfortable, with extra” (20.7% vs. 41.0%), almost twice as likely to report having to cut back (21.3% vs. 12.7%), and four times as likely to report not being able to make ends meet (20.7% vs 5.2%).

Educational completion of participants was significantly different for both trans and non-binary participants when compared with cisgender participants (Table 2). Trans participants were more likely to report not completing high school (12.5% vs. 3.3%), only completing high school or equivalent (30.4% vs. 16.9%), and only completing post-secondary school (28.4% vs. 25.1%), and less likely to report completing a Bachelor’s degree (19.3% vs. 32.2%) or above a bachelor’s degree (9.5% vs. 22.1%) than cisgender participants. After adjusting for confounding variables, trans participants were still statistically significantly less likely to have completed a bachelor’s degree or above a bachelor’s degree. Non-binary participants were significantly less likely to report completing a Bachelor’s degree (24.0% vs. 32.2%) or above a Bachelor’s degree (8.0% vs. 22.1%), and significantly more likely to report completing post-secondary school (28.7% vs. 25.1%). However, none of these relationships proved statistically significant after adjusting for confounders. In the following tables, each variable was assessed in a separate model while adjusting for the same confounders.

Table 2. Education, relationship status, mental health, and substance use among cisgender, trans, and non-binary participants.

Overall Cisgender Trans Non-binary
Level of education n % n % n % OR AOR n % OR AOR
Did not finish high school 155 4.4% 103 3.3% 37 12.5% Ref Ref 12 8.0% Ref Ref
High school or equivalent 646 18.3% 521 16.9% 90 30.4% 0.48 (0.31–0.75) 0.63 (0.38–1.06) 47 31.3% 0.77 (0.41–1.57) 1.53 (0.69–3.67)
Post-secondary school (e.g. certificate, diploma) 897 25.5% 775 25.1% 84 28.4% 0.30 (0.20–0.47) 0.75 (0.45–1.27) 43 28.7% 0.48 (0.25–0.97) 1.64 (0.73–4.03)
Bachelor’s degree 1079 30.6% 994 32.2% 57 19.3% 0.16 (0.10–0.25) 0.50 (0.29–0.87) 36 24.0% 0.31 (0.16–0.64) 1.53 (0.66–3.83)
Above a bachelor’s degree (e.g., masters, doctorate) 724 20.5% 680 22.1% 28 9.5% 0.11 (0.07–0.19) 0.46 (0.24–0.87) 12 8.0% 0.15 (0.07–0.35) 0.79 (0.28–2.30)
Relationship Status
No 1661 47.1% 1460 47.4% 135 45.6% Ref Ref 73 48.7% Ref Ref
Yes, with a man 1580 44.8% 1452 47.1% 77 26.0% 0.57 (0.43–0.76) 0.86 (0.62–1.18) 33 22.0% 0.45 (0.30–0.68) 0.62 (0.38–0.98)
Yes, with a woman 126 3.6% 87 2.8% 33 11.1% 4.10 (2.62–6.30) 1.07 (0.65–1.73) 13 8.7% 2.99 (1.53–5.43) 0.75 (0.36–1.43)
Yes, with a non-binary person 26 0.7% 12 0.4% 12 4.1% 10.81 (4.72–24.79) 2.70 (1.00–7.32) 6 4.0% 10.00 (3.40–26.52) 1.79 (0.44–6.21)
Yes, with more than 1 person (polyamorous) 96 2.7% 55 1.8% 34 11.5% 6.69 (4.18–10.57) 3.98 (2.30–6.85) 25 16.7% 9.09 (5.30–15.30) 5.14 (2.69–9.70)
Depression Scores
< Score of 3 2774 78.7% 2500 81.1% 182 61.5% Ref Ref 88 58.7% Ref Ref
≥ Score of 3 502 14.2% 386 12.5% 89 30.1% 3.17 (2.40–4.16) 1.77 (1.27–2.43) 50 33.3% 3.68 (2.54–5.27) 2.00 (1.30–3.04)
Anxiety Scores
< Score of 3 2643 75.0% 2404 78.0% 155 52.4% Ref Ref 74 49.3% Ref Ref
≥ Score of 3 628 17.8% 480 15.6% 115 38.9% 3.72 (2.86–4.82) 2.11 (1.56–2.86) 63 42.0% 4.26 (3.00–6.05) 2.37 (1.57–3.55)
Help Wanted With Mental Health Issues (ref: no)
Depression 820 23.3% 651 21.1% 140 47.3% 3.60 (2.79–4.65) 2.26 (1.69–3.01) 61 40.7% 2.54 (1.79–3.58) 1.55 (1.04–2.29)
Anxiety 984 27.9% 801 26.0% 146 49.3% 2.98 (2.31–3.84) 2.15 (1.61–2.88) 69 46.0% 2.42 (1.72–3.41) 1.87 (1.27–2.76)
Gender dysphoria/transition 123 3.5% 17 0.6% 100 33.8% 96.76 (58.04–171.01) 44.32 (25.19–82.07) 48 32.0% 85.32 (48.17–158.05) 45.46 (22.87–94.27)
Eating disorders 195 5.5% 132 4.3% 54 18.2% 5.07 (3.57–7.13) 2.80 (1.84–4.22) 30 20.0% 5.51 (3.50–8.46) 2.85 (1.66–4.80)
Body image 621 17.6% 497 16.1% 108 36.5% 3.10 (2.38–4.03) 2.30 (1.69–3.12) 56 37.3% 3.09 (2.16–4.37) 2.19 (1.46–3.27)
Suicidal thoughts 240 6.8% 171 5.5% 62 20.9% 4.60 (3.31–6.32) 2.30 (1.56–3.35) 24 16.0% 3.18 (1.95–4.98) 1.32 (0.75–2.25)
Mental Health resources used, past year (ref: no)
Elder (Indigenous) 83 2.4% 60 1.9% 16 5.4% 2.90 (1.59–4.98) 1.95 (0.95–3.84) 11 7.3% 3.86 (1.88–7.23) 2.00 (0.82–4.51)
Knowledge Keeper (Indigenous) 51 1.4% 36 1.2% 13 4.4% 3.91 (1.98–7.29) 3.64 (1.61–7.85) 9 6.0% 5.23 (2.32–10.63) 3.46 (1.24–8.79)
Psychiatrist 414 11.7% 320 10.4% 78 26.4% 3.19 (2.38–4.24) 1.80 (1.29–2.50) 38 25.3% 2.86 (1.91–4.19) 1.59 (1.00–2.46)
Clinical psychologist 325 9.2% 269 8.7% 47 15.9% 2.01 (1.42–2.80) 1.67 (1.12–2.44) 25 16.7% 2.04 (1.28–3.16) 1.71 (1.00–2.81)
Registered counsellor 486 13.8% 378 12.3% 91 30.7% 3.30 (2.50–4.35) 2.28 (1.66–3.12) 49 32.7% 3.42 (2.36–4.90) 2.46 (1.61–3.71)
Peer counsellor/Navigator 179 5.1% 124 4.0% 47 15.9% 4.60 (3.17–6.57) 3.71 (2.41–5.67) 23 15.3% 4.21 (2.54–6.70) 2.94 (1.63–5.12)
Social worker 303 8.6% 209 6.8% 75 25.3% 4.83 (3.56–6.52) 2.50 (1.74–3.57) 45 30.0% 5.83 (3.95–8.50) 3.05 (1.91–4.80)
None of the above 1984 56.3% 1826 59.2% 92 31.1% 0.27 (0.21–0.35) 0.44 (0.33–0.60) 48 32.0% 0.27 (0.19–0.38) 0.46 (0.31–0.70)
Any Substance Use, Past 6 Months
Yes 2580 73.2% 2272 73.7% 219 74.0% Ref Ref 113 75.3% Ref Ref
No 658 18.7% 582 18.9% 48 16.2% 1.17 (0.85–1.63) 0.97 (0.67–1.42) 27 18.0% 1.07 (0.71–1.68) 0.90 (0.56–1.52)

Just less than half of participants in each group were single, with all three groups having approximately the same proportion of respondents who were single (45.6% of trans participants, 48.7% of non-binary participants, and 47.4% of cisgender participants) (Table 2). However, the gender of participants’ partners varied significantly for trans and non-binary participants compared with cisgender participants. Approximately half as many trans and non-binary participants were in a relationship with a man (26.0% for trans and 22.0% for non-binary compared with 47.1% of cisgender participants). Trans respondents were significantly more likely than cisgender participants to be in a polyamorous relationship (11.5% vs. 1.8%), partnered with a woman (11.1% vs. 2.8%), or partnered with a non-binary person (4.1% vs 0.4%). After controlling for confounding variables, trans participants remained statistically more likely to be in polyamorous relationships compared with cisgender participants. Non-binary participants were also more likely than cisgender participants to be in a polyamorous relationship (16.7% vs. 1.8%), partnered with a woman (8.7% vs. 2.8%), or partnered with a non-binary person (4.0% vs 0.4%). Non-binary participants remained significantly less likely to be in a relationship with a man and significantly more likely to be in a polyamorous relationship after controlling for confounders when compared with cisgender participants. This question did not specify whether a man or woman partner was cisgender or transgender, which limits our understanding.

Mental health and substance use

When trans and non-binary participants were compared to cisgender participants, statistically significant differences in depression scores emerged (Table 2). Nearly a third of trans (30.1%) and non-binary participants (33.3%) scored greater than or equal to 3, compared with only 1 in 8 (12.5%) cisgender participants. These results remained statistically significant after adjusting for confounding variables. Similarly, statistically significant differences were found when anxiety scores where compared across groups (Table 2). Approximately 2 in 5 trans (38.9%) and non-binary participants (42.0%) scored a 3 or higher on the GAD-2, compared to 15.6% of cis participants. After adjusting for confounding variables, differences in anxiety scores remained statistically significant for both trans and non-binary participants.

When participants were asked if they wanted help with a variety of mental health issues, there were statistically significant differences between both trans and non-binary participants and cisgender participants on almost every issue (Table 2). Trans and non-binary participants were both significantly more likely than cisgender participants to indicate they wanted help with depression and anxiety. Nearly half of trans respondents wanted help for depression (47.3%) and anxiety (49.3%). About 2 in 5 non-binary participants wanted help for depression (40.7%) and nearly half for anxiety (46.0%). In contrast, roughly one-fifth (21.1%) of cisgender participants indicated the same for depression and 1 in 4 (26.0%) indicated the same for anxiety. Differences in depression and anxiety scores for trans and non-binary participants in comparison to cisgender participants remained statistically significant after adjusting for confounders.

Besides depression and anxiety, the most common issue with which participants wanted help was body image, regardless of gender identity, with 36.5% of trans participants and 37.3% of non-binary participants reporting this—more than double that of cisgender participants (16.1%). Highly statistically significant results were observed for help wanted with gender dysphoria/transition, with approximately a third of trans (33.8%) and non-binary (32.0%) participants indicating wanting help with this compared to 0.6% of cisgender participants. Statistically significant differences also resulted when comparing help wanted with eating disorders (18.2% of trans and 20.0% of non-binary participants vs. 4.3% of cisgender participants) and suicidal thoughts (20.9% of trans and 16.0% of non-binary participants vs. 5.5% of cisgender participants). After adjusting for confounding variables, all these results remained statistically significant with the exception of findings about suicidal thoughts when comparing non-binary and cisgender participants.

In general, significantly more trans participants and non-binary participants used resources for health in the past year than cisgender participants (Table 2). Less than a third of trans participants (31.1%) and non-binary participants (32.0%) reported not having used any of the health resource in the past year compared with 3 in 5 (59.2%) cisgender respondents. Trans participants and non-binary participants were approximately three times more likely than Indigenous cisgender participants to access support from an Indigenous Elder, and approximately four times more likely to visit an Indigenous Knowledge Keeper (five times more likely for non-binary participants). Recall that compared with cisgender participants, twice as many Indigenous participants were trans and non-binary. With the exception of trans participants’ access to Elders, these results remained statistically significant after adjusting for confounding variables.

Compared with cisgender participants, trans participants were more likely to have gone to a registered counsellor (30.7% vs. 12.3%), a psychiatrist (26.4% vs. 10.4%), a social worker (25.3% vs. 6.8%), a clinical psychologist (15.9% vs. 8.7%) and a peer counsellor/navigator (15.9% vs. 4.0%). All these results were statistically significant after adjusting for confounding variables. Compared with cisgender participants, non-binary participants were more likely to have gone to a registered counsellor (32.7% vs. 12.3%), a social worker (30.0% vs. 6.8%), a psychiatrist (25.3% vs. 10.4%), a clinical psychologist (16.7% vs. 8.7%) and a peer counsellor/navigator (15.3% vs. 4.0%). However, the results for psychiatrist and clinical psychologist were no longer statistically significant after adjusting for confounding variables.

Overall, there were no statistically significant differences across gender identity groups when asked if they had used any substances (i.e., alcohol or drugs) in the past 6 months (Table 2). This was reported by approximately three quarters of trans participants (74.0%), non-binary participants (75.3%), and cisgender participants (73.7%).

Sexual health

Participants were asked a series of questions about their sexual health, including whether they had had chlamydia, gonorrhea, or syphilis in the past year (Table 3). Trans participants were significantly less likely to report having had one of these STIs in the past year when compared with cisgender participants (9.8% vs. 16.4%), however this was no longer statistically significant after adjusting for confounding variables. There was no significant difference between non-binary and cisgender participants in their reporting of these STIs in the past year (12.0% vs. 16.4%).

Table 3. Sexual health, Hepatitis C, and HIV among cisgender, trans, and non-binary participants.

Overall Cisgender Trans Non-Binary
Chlamydia, gonorrhea, or syphilis, past year n % n % n % OR AOR n % OR AOR
Yes 559 15.9% 507 16.4% 29 9.8% 0.62 (0.41–0.91) 0.89 (0.57–1.36) 18 12.0% 0.74 (0.43–1.21) 1.04 (0.58–1.80)
No 2540 72.1% 2244 72.8% 208 70.3% Ref Ref 107 71.3% Ref Ref
Timing of Last STI Test
In the past year 2373 67.3% 2113 68.5% 177 59.8% Ref Ref 93 62.0% Ref Ref
Longer than a year ago 691 19.6% 619 20.1% 48 16.2% 0.93 (0.66–1.28) 0.92 (0.63–1.33) 25 16.7% 0.92 (0.57–1.42) 0.86 (0.50–1.42)
Never 278 7.9% 216 7.0% 46 15.5% 2.54 (1.77–3.59) 1.05 (0.68–1.58) 20 13.3% 2.10 (1.24–3.41) 0.76 (0.41–1.34)
Samples collected during last STI test (ref: no)
Urine test 2438 69.2% 2196 71.2% 172 58.1% 0.73 (0.54–0.99) 0.69 (0.49–0.99) 91 60.7% 0.77 (0.51–1.82) 0.79 (0.49–1.31)
Blood sample 2872 81.5% 2569 83.3% 205 69.3% 0.56 (0.37–0.86) 0.95 (0.59–1.56) 109 72.7% 0.66 (0.38–1.25) 1.33 (0.69–2.80)
Throat swab 1521 43.2% 1391 45.1% 87 29.4% 0.59 (0.44–0.77) 0.77 (0.56–1.04) 46 30.7% 0.60 (0.41–0.87) 0.82 (0.54–1.24)
Rectal swab (in your bum) 1151 32.7% 1055 34.2% 63 21.3% 0.60 (0.44–0.80) 0.87 (0.62–1.21) 36 24.0% 0.68 (0.45–1.00) 1.09 (0.69–1.69)
None of the above 85 2.4% 67 2.2% 8 2.7% 1.43 (0.63–2.84) 1.02 (0.42–2.24) 5 3.3% 1.73 (0.60–3.96) 1.00 (0.28–2.81)
Ever Tested for HCV
Yes 2507 71.1% 2240 72.7% 179 60.5% Ref Ref 94 62.7% Ref Ref
No 327 9.3% 263 8.5% 53 17.9% 2.52 (1.80–3.50) 1.20 (0.79–1.77) 18 12.0% 1.63 (0.94–2.68) 0.75 (0.39–1.36)
Ever diagnosed with HCV
No 2431 69.0% 2211 71.7% 165 55.7% Ref Ref 87 58.0% Ref Ref
Yes 33 0.9% 26 0.8% 4 1.4% 2.14 (0.63–5.60) 1.08 (0.28–3.41) 3 2.0% 3.05 (0.72–8.91) 2.43 (0.46–9.85)
Ever Tested for HIV
Yes 3004 85.2% 2691 87.3% 210 70.9% Ref Ref 109 72.7% Ref Ref
No 296 8.4% 230 7.5% 48 16.2% 2.67 (1.88–3.73) 0.88 (0.58–1.31) 23 15.3% 2.47 (1.51–3.88) 0.80 (0.45–1.36)
Ever Diagnosed with HIV
No 2745 77.9% 2459 79.8% 193 65.2% Ref Ref 103 68.7% Ref Ref
Yes 225 6.4% 200 6.5% 15 5.1% 0.96 (0.53–1.59) 1.43 (0.75–2.56) 8 5.3% 3.05 (0.72–8.91) 0.68 (0.65–3.81)
Ever used HIV PrEP
No 2649 75.2% 2300 74.6% 246 83.1% Ref Ref 123 82.0% Ref Ref
Yes, but I stopped 96 2.7% 80 2.6% 13 4.4% 1.52 (0.80–2.68) 2.96 (1.45–5.65) 5 3.3% 1.17 (0.41–2.66) 2.34 (0.73–6.06)
Yes, I’m taking PrEP now! 400 11.4% 379 12.3% 12 4.1% 0.30 (0.16–0.51) 0.56 (0.28–1.00) 7 4.7% 0.35 (0.15–0.69) 0.73 (0.29–1.53)

When compared with cisgender participants, trans and non-binary participants were less likely to have been tested for STIs in the past year (Table 3). About 3 in 5 trans (59.8%) and non-binary participants (62.0%) had been tested in past year, compared with 68.5% of cisgender participants. Trans participants (15.5%) and non-binary participants (13.3%) were approximately twice as likely to report never having been tested for STIs compared to cisgender participants (7.0%). These findings were no longer statistically significant after adjusting for confounders. There were no significant differences when comparing non-binary and cisgender participants. Participants were asked to report whether various issues had caused them to delay or skip STI testing over the past year. Across all participants, the most commonly reported issues encountered were being too busy (25.1%), hours being inconvenient (15.4%), and feeling “stressed out, anxious, or depressed” (10.4%).

Generally, trans and non-binary participants were less likely to have had various samples collected during their most recent STI test (Table 3). When compared with cisgender participants, trans participants were significantly less likely to have completed a urine test (58.1% vs. 71.2%), blood sample (69.3% vs. 83.3%), throat swab (29.4% vs. 45.1%), or rectal swab (21.3% vs. 34.2%) during their most recent STI test. Most of these relationships were no longer statistically significant after adjusting for confounding variables, but trans participants remained significantly less likely to have completed a urine test after these adjustments were made. When compared with cisgender participants, the only statistically significant finding for non-binary participants was that they were less likely to have completed a throat swab (30.7% vs. 45.1%), although they were also less likely to have completed a urine test (60.7% vs. 71.2%), blood sample (72.7% vs. 83.3%), or rectal swab (24.0% vs. 34.2%).

When asked if they had ever tested for hepatitis C, trans participants were significantly less likely to have ever tested compared to cisgender participants (Table 3). Twice as many trans participants (17.9%) reported never having tested when compared to cisgender participants (8.5%). This relationship was no longer statistically significant after adjusting for confounders. Non-binary participants were also more likely to have never tested for hepatitis C (12.0%) when compared with cisgender participants (8.5%), but this was not a statistically significant relationship. Participants were asked if they had ever been diagnosed with hepatitis C (Table 3). Generally, rates of hepatitis C diagnosis were low across the sample with no statistically significant differences across gender groups. However, trans participants were nearly twice as likely as cisgender participants to report a diagnosis (1.4% vs. 0.8%), while non-binary participants were 2.5 times more likely to report a diagnosis (2.0%).

When asked if they had ever been tested for HIV, trans and non-binary participants were significantly more likely to report never having been tested compared to cisgender participants (Table 3). Over twice as many trans (16.2%) and non-binary (15.3%) participants reported never having been tested compared to cisgender participants (7.5%). Neither relationship was statistically significant after adjusting for confounding variables. Prevalence of HIV diagnosis across gender groups were similar, with no statistically significant differences (Table 3).

Participants who were not living with HIV were asked if they had ever used PrEP and whether they were currently using it (Table 3). Trans and non-binary participants were significantly less likely (2 to 3 times) to report currently using PrEP when compared with cisgender participants. Approximately 1 in 25 trans participants (4.1%) and 1 in 20 non-binary participants (4.7%) were currently using PrEP, compared to 1 in 8 cisgender participants. Adjusting for confounders rendered these findings no longer statistically significant. Trans participants were also more likely to report having started using PrEP and stopped when compared with cisgender participants (4.4% vs. 2.6%). This became a statistically significant finding after adjusting for confounding variables. Participants who were not using PrEP were asked to report what stops them from taking PrEP. Across all groups, the most common reasons reported were “I don’t think I’ll get HIV” (25.8%), cost (19.8%), side effects (14.7%), and none of the above (15.9%).

Healthcare access

Participants were asked a series of questions about healthcare access, including if they had a regular doctor or nurse practitioner (Table 4). There were no statistically significant differences in access to a regular healthcare provider when non-binary participants were compared with cisgender participants (71.3% vs. 71.7%). However, trans participants were more likely to have a regular doctor or nurse practitioner when compared with cisgender participants (76.4% vs. 71.7%). This became a statistically significant finding after adjusting for confounding variables.

Table 4. Healthcare access, vaccinations, among cisgender, trans, and non-binary participants.

Overall Cisgender Trans Non-Binary
Has regular HCP n % n % n % OR AOR n % OR AOR
No 851 24.1% 752 24.4% 59 19.9% Ref Ref 40 26.7% Ref Ref
Yes 2524 71.6% 2212 71.7% 226 76.4% 1.30 (0.97–1.77) 1.82 (1.30–2.57) 107 71.3% 0.91 (0.63–1.33) 1.53 (1.00–2.38)
Ever vaccinated for HBV
No 435 12.3% 367 11.9% 40 13.5% Ref Ref 21 14.0% Ref Ref
Unsure 546 15.5% 459 14.9% 66 22.3% 1.32 (0.87–2.01) 1.23 (0.77–1.99) 34 22.7% 1.29 (0.74–2.30) 1.18 (0.63–2.24)
Yes 2336 66.3% 2092 67.9% 173 58.4% 0.76 (0.53–1.10) 1.15 (0.77–1.76) 88 58.7% 0.74 (0.46–1.23) 1.09 (0.64–1.94)
Ever vaccinated for HPV
No 1361 38.6% 1221 39.6% 86 29.1% Ref Ref 41 27.3% Ref Ref
Unsure 709 20.1% 605 19.6% 75 25.3% 1.76 (1.27–2.43) 1.21 (0.83–1.74) 38 25.3% 1.87 (1.19–2.94) 1.29 (0.77–2.14)
Yes 1083 30.7% 942 30.6% 113 38.2% 1.70 (1.27–2.29) 1.51 (1.08–2.12) 54 36.0% 1.71 (1.13–2.60) 1.47 (0.92–2.36)
Asked and Denied (ref: no)
An HIV test 124 3.5% 103 3.3% 17 5.7% 1.75 (1.00–2.89) 1.29 (0.68–2.30) 9 6.0% 1.85 (0.85–3.55) 1.40 (0.60–2.94)
PEP 42 1.2% 32 1.0% 8 2.7% 2.61 (1.11–5.46) 2.29 (0.87–5.42) 3 2.0% 1.95 (0.46–5.52) 1.69 (0.35–5.77)
PrEP 80 2.3% 72 2.3% 7 2.4% 1.00 (0.41–2.04) 0.99 (0.37–2.25) 3 2.0% 0.85 (0.21–2.32) 0.87 (0.19–2.67)
HPV vaccination 62 1.8% 49 1.6% 12 4.1% 2.58 (1.30–4.76) 2.78 (1.25–5.79) 5 3.3% 2.14 (0.73–4.97) 1.87 (0.56–5.19)
Hormone therapy 57 1.6% 9 0.3% 46 15.5% 63.13 (32.00–139.36) 31.60 (14.43–75.96) 20 13.3% 53.26 (24.41–125.38) 24.82 (9.19–72.61)
Gender affirming surgery 42 1.2% 5 0.2% 36 12.2% 84.95 (36.15–249.04) 50.65 (19.10–161.85) 14 9.3% 63.92 (24.04–200.38) 36.71 (10.69–144.38)
None of the above 2891 82.0% 2595 84.2% 192 64.9% 0.20 (0.15–0.26) 0.24 (0.17–0.34) 102 68.0% 0.24 (0.16–0.37) 0.28 (0.17–0.46)

When asked if they had ever been vaccinated against hepatitis B, no statistically significant findings emerged when comparing trans and non-binary participants to cisgender participants (Table 4). Trans participants were more likely to indicate never having been vaccinated (13.5% vs. 11.9%) or being unsure of their vaccination status (22.3% vs. 14.9%) in comparison to cisgender participants. Similarly, non-binary participants were more likely to indicate never having been vaccinated (14.0% vs. 11.9%) or being unsure of their vaccination status (22.7% vs. 14.9%).

However, statistically significant differences emerged in terms of HPV vaccination upon comparison across gender groups (Table 4). Trans and non-binary participants were less likely to report never having been vaccinated when compared with cisgender participants (29.1% of trans participants, 27.3% of non-binary participants, and 39.6% of cisgender participants). Compared with cisgender participants, trans participants were significantly more likely to indicate being vaccinated against HPV (38.2% vs. 30.6%) and being unsure of their vaccination status (25.3% vs. 19.6%). After adjusting for confounding variables, trans participants were still significantly more likely to report being vaccinated for HPV. Non-binary participants were also significantly more likely to indicate being vaccinated against HPV (36.0% vs. 30.6%) and being unsure of their vaccination status (25.3% vs. 19.6%) in comparison to cisgender participants. However, these findings were not statistically significant after adjusting for confounders.

Finally, participants were asked if they had ever asked for and been denied a variety of health services (Table 4). Trans and non-binary participants were both significantly less likely to report having never been denied one of the listed services in comparison to cisgender participants (64.9% of trans participants, 68.0% of non-binary participants, and 84.2% of cisgender participants), and this remained statistically significant after adjusting for confounding variables. Compared to cisgender participants, trans participants were also significantly more likely to report being denied PEP [post-exposure prophylaxis] (2.7% vs 1.0%), HPV vaccination (4.1% vs. 1.6%), hormone therapy (15.5% vs. 0.3%), and gender affirming surgery (12.2% vs. 0.2%). Results remained statistically significant for all these health services after adjusting for confounding variables, with the exception of being denied PEP. Non-binary participants were significantly more likely to report being denied hormone therapy (13.3% vs. 0.3%) and gender affirming surgery (9.3% vs. 0.2%) when compared with cisgender participants, and both relationships remained highly statistically significant after adjusting for confounders.

Discussion

This study aimed to illuminate the health and socio-demographic characteristics of transgender and non-binary populations in Canada. Using data from Sex Now 2018, we compared cisgender participants with trans participants and with non-binary participants across a number of characteristics. We begin with a discussion of healthcare related differences followed by mental health and sociodemographic drivers. Where possible, throughout this discussion, literature specific to Canada is used to give context to and support our results.

Our current study highlights a number of important differences in trans and non-binary people’s experiences and needs with respect to general healthcare and more specifically sexual health. Trans people reported fewer STIs over the last year and less testing for STIs. Significantly, they were more likely to never have been tested for HIV, which reflects existing evidence that trans men test less frequently for HIV and STIs [68]. Although we did not report on participants’ sexual behaviours, existing literature also suggests lower prevalence of high-risk sexual encounters among trans men [6, 7], which may contribute to lower levels of perceived risk and therefore reduced rates of HIV and STI testing. Indeed, when asked why they did not use PrEP, trans and non-binary participants were more likely to report perceived low risk for getting HIV. This low risk perception may be due to engaging in sexual behaviours that are considered low risk, utilizing other strategies to reduce risk, or engaging in sex with people they know to be HIV negative [15]. However, low rates of testing among trans and non-binary participants may also be indicative of participants’ discomfort in accessing sexual health services in gendered spaces (e.g. women’s clinic or gay men’s health clinic). In addition, they could avoid testing or other sexual healthcare due to fears of mistreatment by healthcare providers, as other studies have found [16].

Trans participants reported higher rates of access to a regular healthcare provider when compared to the cisgender group, while non-binary participants reported access at similar rates to cisgender participants. Despite this, differences likely exist in the quality of care received by trans and non-binary people. Several other studies have highlighted gaps in healthcare provider competence for trans people’s health [17, 18]. Others found that trans respondents need to educate their healthcare providers in order to receive appropriate care [19, 20]. These experiences may lead trans and non-binary people to delay care or not access certain services. Indeed, the health of trans people is likely impacted by challenges with accessing gender-affirming care [21]. In the present study, we did not specifically ask trans respondents whether they felt their healthcare provider was trans competent or affirming of their gender and, therefore, cannot draw related conclusions. There is a need for more research specific to healthcare access and quality for trans and non-binary people who belong to sexual minority groups.

Regarding mental health, statistically significant differences existed in the depression and anxiety scores of trans and non-binary participants when compared with cis participants, with trans and non-binary people reporting higher rates of depression and anxiety. This adds to a body of literature that demonstrates that trans people face mental health challenges at much higher rates [2, 22] than cisgender people [23]. Further, sexual minorities are more likely than heterosexual people to experience mental health challenges that include depression, anxiety, and suicidality [24]. For our trans and non-binary participants who were also sexual minorities, these multiple identities may increase the likelihood of experiencing depression or anxiety. Additional factors contribute to poor mental health within trans and non-binary communities, including transphobia, discrimination, and stigma, which reduce overall well-being and increase suicidality [25, 26]. Trans and non-binary people reported wanting help for depression and anxiety more than cisgender participants and used resources for mental health more often. Despite wanting and utilizing more mental health services, trans and non-binary people still experienced poorer mental health. Few trans-specific mental health services may be available to our sample [2], and those that do exist may be unsatisfactory and/or ineffective at meeting trans and non-binary people’s needs. A comprehensive mental health research strategy and response plan is recommended to address health inequities experienced by these communities. Future research and evaluation efforts must carefully study the effectiveness of these resources and their ability to address the unique needs and desires of trans and non-binary people.

Our sample of trans and non-binary participants had several notable differences in sociodemographic drivers of healthcare access and outcomes, which both support and diverge from existing literature about the demographics of trans and non-binary populations. The proportion of trans and non-binary people in our sample was high compared with the general population [27], especially for those with non-binary or genderfluid identities, which may reflect the demographic composition of Pride festival attendees. Similarly, TransPulse Ontario found about 40% of their trans sample identified as ‘fluid’ or having a non-binary gender identity [28]. Surprisingly, we did not recruit a significantly larger number of trans and non-binary people in major cities, where more healthcare services targeted for trans people typically exist, and more liberal political landscapes may provide policies that support trans rights. Our sample of trans and non-binary people was significantly younger than our cisgender sample, which may be due to our recruitment occurring through Pride festivals, which younger people may be more likely to attend. Some literature points to a recent trend of more people coming out as trans or non-binary, and at younger ages; this may explain the skew of our sample toward younger participants [29]. Research and programs need better strategies to reach and engage with older trans and non-binary people, especially those who may not identify with “LGBTQ2S+” or sexual orientation minority groups, spaces or places, as older trans and non-binary people may have different experiences and needs.

Trans respondents were more likely to be born in Canada than cisgender participants; this may reflect challenges trans people face in immigrating to Canada. Future work should examine related policies and the immigration experiences of trans people in more detail since it is outside the scope of this analysis. The results of this study add to growing literature about sexual orientation among trans and non-binary people. Trans people in our sample were significantly more likely to identify as queer, and many used pansexual or bisexual to describe their sexual orientation. This corroborates findings from TransPulse Canada, whose participants mostly did not self-identify as heterosexual (8% reported being heterosexual) [5]. We found trans and non-binary people to be single at the same rates as cisgender participants; however, trans and non-binary people were significantly more likely to be in polyamorous relationships. These relationships may provide unique opportunities, challenges, and strengths for trans and non-binary people that should not be ignored. Future research, policy, and programs should not assume or require monogamy and should affirm diverse sexual partnership formations.

Our participants’ reports of educational attainment corroborate some existing studies [30], as trans and non-binary participants generally received less post-secondary education than cisgender participants. Other studies show higher educational attainment among trans people, yet higher rates of unemployment and low income despite this [31]. This likely reflects the younger age composition of our trans and non-binary participants. In terms of finances, trans and non-binary participants reported being less financially comfortable than their cisgender counterparts. In Canada in 2018, 12.5% of the general population met the Statistics Canada threshold for being low income [32]. Our survey did not ask whether participants met the criteria for being considered low income, however, 17% of trans and 21% of non-binary people reported not being able to make ends meet. Our findings echo the results of several other studies which demonstrate that trans people are more likely to be low income or unemployed. For example, among TransPulse Canada respondents, 26% had an income of less than $15,000 a year [5]. These economic barriers may impact the overall health and well-being of this population [17]. Greater supports throughout primary, secondary, and tertiary education could help reduce socioeconomic disparities experienced by trans and non-binary individuals. Further, stronger and more active employment protections for trans and non-binary people are needed to ensure equity in hiring processes, workplace environments, and compensation. Future research should examine educational goals, experiences, and retention in programs, and generally explore what kinds of efforts to increase formal education and training may be necessary and desired among trans and non-binary communities.

Limitations and future research

Our findings show that differences in health outcomes exist for cisgender, transgender, and non-binary people in Canada, drawn from a survey of GBT2Q+ people. While our study adds to a growing body of evidence that trans people have unique health and healthcare concerns, it is not without limitations. The Sex Now survey is not a comprehensive study of all issues affecting trans and non-binary people in Canada and did not collect some information that may have enhanced the conclusions we can draw from this analysis. Furthermore, the Sex Now study is generally known and promoted as a survey of “sex between guys,” although more detailed language and specific eligibility was available in the current survey cycle. This men-focussed approach erases non-binary people, and some potentially eligible trans and non-binary people may have not participated because the language was not inclusive. Future surveys of sexual and gender minority populations should be more intentional about the inclusion of trans and non-binary people (e.g., consider over-recruitment, explicitly recruit from trans and non-binary spaces such as Trans Pride parades, hire trans and non-binary people as study staff and recruiters). Although we noted greater diversity among trans and non-binary participants in terms of sexual identities, it is worth noting that this sample was recruited at Pride festivals in urban centres. Accordingly, this study and report do not fully represent the experiences of heterosexual trans men and heterosexual non-binary people nor trans and non-binary people who do not live in or visit urban centres.

In the survey, we asked two questions about sex and gender to delineate the categories of transgender and non-binary for our analysis, as described in the Methods section of this paper. First, “What is your gender identity?” And second, “Do you have trans experience?” The latter question was used as an attempt to be inclusive of those who have transitioned but do not use the term transgender to (currently) describe their identity. A different two-step method of determining who is trans has been utilized in other publications [33]. This includes asking gender identity and sex assigned at birth. Using these questions would make our data more easily comparable with other studies, yet, during consultations with community members, we received feedback that the question of sex assigned at birth was invasive and not necessary for our purposes. Due to our method of gender grouping and the small number of participants who identified as non-binary and not trans (n = 44), we were unable to directly compare trans and non-binary respondents for this analysis as the two categories largely overlapped; this may also influence our interpretation of results. In the future, analyses that allow for more nuanced comparison across gender categories (e.g., cisgender, exclusively trans, exclusively non-binary, both trans and non-binary) may yield different findings. Additionally, gender groupings for this report were determined through self-reported responses to two survey questions, so participants who skipped these questions or answered “prefer not to say” are not represented in these results.

Future intersectional research may provide valuable insights into the health of trans and non-binary people in Canada [34]. Several areas of inquiry in this study would benefit from more research. First, the ethnoracial make-up of our sample is notable with a large portion of trans and non-binary people identifying as Indigenous; there is little research on ethnicity and race within the trans population. Of note, we did not fully or explicitly address Two-Spirit participants into this analysis; additional resources should be invested into Indigenous Two-Spirit research to produce culturally relevant knowledge on the unique experiences of Indigenous and Two-Spirit people. Our sample did not show statistically significant differences between substance use for the groups we compared, while other studies have found higher rates of use among trans people than cisgender people [35, 36]. Other studies have theorized substance use as a coping mechanism for people who experience marginalization, including trans and non-binary people [37]. It is unclear why our sample does not reflect the findings of others. In the future, qualitative data collection may be useful in understanding this phenomenon. Lastly, a portion of our trans and non-binary respondents indicated being denied access to hormone therapy or gender-affirming surgery; with no follow-up questions, we cannot explain why these individuals were denied the care they asked for. Gender-affirming surgery has been shown to increase mental health and overall well-being for those who need and access it [38, 39]. Those denied surgery may, therefore experience poor mental health, overall health or well-being. Future research should examine the reasons for being denied care and determine ways to support trans and non-binary people’s health until they can access these essential services.

Conclusion

In summary, trans and non-binary people experience significant disadvantages compared with cisgender sexual minority men. We highlight a number of areas for future research and interventions to understand and address health and social inequities of trans and non-binary people with respect to education, employment, mental health, and sexual health. Improved educational supports and employment protections, access to queer and gender affirming healthcare, and trauma-informed mental health services are needed to improve the health and wellbeing of trans and non-binary people in Canada.

Acknowledgments

The authors would like to thank the 2018 Sex Now Survey participants, the Community-Based Research Centre, and all our community partners for assisting in data collection for this study. Additionally, we would like to thank our trans and non-binary community consultants and members of CBRC’s Research Working Group for their input on our preliminary results, which are available in a publicly accessible report: https://www.cbrc.net/community_profiles_trans_non_binary_people.

Data Availability

Partial Sex Now data is publicly available on the Our Stats dashboard (https://ourstats.ca/our-dashboard). The University of Victoria’s Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to University of Victoria’s Human Research Ethics Board (250-472-4545 or ethics@uvic.ca).

Funding Statement

Sex Now 2018 received funding support from Canadian Blood Services MSM Research Fund, funded by the federal government (Health Canada) and the provincial and territorial ministries of health. The views herein do not necessarily reflect the views of Canadian Blood Services or the federal, provincial, or territorial governments of Canada. Additional in-kind contributions were received from the Public Health Agency of Canada’s National Microbiology Laboratory. Additional funding for this analysis was provided by Women and Gender Equality (WAGE) Canada. NJL is supported by a Scholar Award from the Michael Smith Foundation for Health Research (#16863).

References

  • 1.Bauer GR, Scheim AI, Deutsch MB, Massarella C. Reported Emergency Department Avoidance, Use, and Experiences of Transgender Persons in Ontario, Canada: Results From a Respondent-Driven Sampling Survey. Ann Emerg Med. 2014. June;63(6):713–720.e1. 10.1016/j.annemergmed.2013.09.027 [DOI] [PubMed] [Google Scholar]
  • 2.Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R. Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada. BMC Public Health. 2015. December;15(1):525 10.1186/s12889-015-1867-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Scheim AI, Bauer GR, Pyne J. Avoidance of Public Spaces by Trans Ontarians: The Impact of Transphobia on Daily Life. Trans PULSE E-Bulletin, No. 8. 2014. http://transpulseproject.ca/wp-content/uploads/2014/01/Trans-PULSE-E-Bulletin-8-English.pdf
  • 4.Taylor AB, Chan A, Hall SL, Saewyc EM, & the Canadian Trans & Non-binary Youth Health Survey Research Group. Being Safe, Being Me 2019: Results of the Canadian Trans and Non-binary Youth Health Survey. Stigma and Resilience Among Vulnerable Youth Centre, University of British Columbia. 2020. https://apsc-saravyc.sites.olt.ubc.ca/files/2020/03/Being-Safe-Being-Me-2019_SARAVYC_ENG-1.pdf
  • 5.The Trans PULSE Canada Team. Health and health care access for trans and non-binary people in Canada. 2020. https://transpulsecanada.ca/results/report-1/
  • 6.Ferlatte O, Panwala V, Rich AJ, Scheim AI, Blackwell E, Scott K, et al. Identifying Health Differences Between Transgender and Cisgender Gay, Bisexual and Other Men Who Have Sex With Men Using a Community-Based Approach. J Sex Res. 2020. March 18;1–9. 10.1080/00224499.2020.1740148 [DOI] [PubMed] [Google Scholar]
  • 7.Scheim AI, Bauer GR, Travers R. HIV-Related Sexual Risk Among Transgender Men Who Are Gay, Bisexual, or Have Sex With Men. J Acquir Immune Defic Syndr. 2017. April;74(4):e89–96. 10.1097/QAI.0000000000001222 [DOI] [PubMed] [Google Scholar]
  • 8.Scheim AI, Travers R. Barriers and facilitators to HIV and sexually transmitted infections testing for gay, bisexual, and other transgender men who have sex with men. AIDS Care. 2017. August 3;29(8):990–5. 10.1080/09540121.2016.1271937 [DOI] [PubMed] [Google Scholar]
  • 9.Rich A, Scott K, Johnston C, Blackwell E, Lachowsky N, Cui Z, et al. Sexual HIV risk among gay, bisexual and queer transgender men: findings from interviews in Vancouver, Canada. Cult Health Sex. 2017. November 2;19(11):1197–209. 10.1080/13691058.2017.1299882 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.James J, Bauer GR, Peck R, Brennan D, Nussbaum N. Legal Problems Facing Trans People in Ontario. TRANSforming JUSTICE Summary Report, No. 1. 2018. HIV & AIDS Legal Clinic Ontario. https://www.halco.org/wp-content/uploads/2020/05/TransForming-Justice-Report-One-2018Sept-EN-updated-May-6-20201.pdf
  • 11.Veale JF, Peter T, Travers R, Saewyc EM. Enacted Stigma, Mental Health, and Protective Factors Among Transgender Youth in Canada. Transgend Health. 2017. December;2(1):207–16. 10.1089/trgh.2017.0031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bauer GR, Travers R, Scanlon K, Coleman TA. High heterogeneity of HIV-related sexual risk among transgender people in Ontario, Canada: a province-wide respondent-driven sampling survey. BMC Public Health. 2012. December;12(1):292 10.1186/1471-2458-12-292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). Journal of Psychosomatic Research. 2005. February;58(2):163–71. 10.1016/j.jpsychores.2004.09.006 [DOI] [PubMed] [Google Scholar]
  • 14.Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection. Ann Intern Med. 2007. March 6;146(5):317 10.7326/0003-4819-146-5-200703060-00004 [DOI] [PubMed] [Google Scholar]
  • 15.Sevelius J. “There’s No Pamphlet for the Kind of Sex I Have”: HIV-Related Risk Factors and Protective Behaviors Among Transgender Men Who Have Sex With Nontransgender Men. Journal of the Association of Nurses in AIDS Care. 2009. September;20(5):398–410. 10.1016/j.jana.2009.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Scheim AI, Santos G-M, Arreola S, Makofane K, Do TD, Hebert P, et al. Inequities in access to HIV prevention services for transgender men: results of a global survey of men who have sex with men. Journal of the International AIDS Society. 2016. July;19:20779 10.7448/IAS.19.3.20779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, et al. Barriers to healthcare for transgender individuals: Current Opinion in Endocrinology & Diabetes and Obesity. 2016. April;23(2):168–71. 10.1093/humupd/dmz026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at every turn: A report of the National Transgender Discrimination Survey. Washington: National Center for Transgender Equality and National Gay and Lesbian Task Force, 2011.
  • 19.Vermeir E, Jackson L, Marshall E. Improving Healthcare Providers’ Interactions with Trans Patients: Recommendations to Promote Cultural Competence. hcpol. 2018. August 15;14(1):11–8. 10.12927/hcpol.2018.25552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Noonan EJ, Sawning S, Combs R, Weingartner LA, Martin LJ, Jones VF, et al. Engaging the Transgender Community to Improve Medical Education and Prioritize Healthcare Initiatives. Teaching and Learning in Medicine. 2018. April 3;30(2):119–32. 10.1080/10401334.2017.1365718 [DOI] [PubMed] [Google Scholar]
  • 21.Sineath RC, Woodyatt C, Sanchez T, Giammattei S, Gillespie T, Hunkeler E, et al. Determinants of and Barriers to Hormonal and Surgical Treatment Receipt Among Transgender People. Transgender Health. 2016. January;1(1):129–36. 10.1089/trgh.2016.0013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Beckwith N, McDowell MJ, Reisner SL, Zaslow S, Weiss RD, Mayer KH, et al. Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center. LGBT Health. 2019. March;6(2):51–61. 10.1089/lgbt.2018.0136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Merikangas KR, He J, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry. 2010. October;49(10):980–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gilmour H. Sexual orientation and complete mental health. Health Reports. 2019:30:11, 3–10. 10.25318/82-003-x201901100001-eng [DOI] [PubMed] [Google Scholar]
  • 25.Wilson EC, Chen Y-H, Arayasirikul S, Raymond HF, McFarland W. The Impact of Discrimination on the Mental Health of Trans*Female Youth and the Protective Effect of Parental Support. AIDS Behav. 2016. October;20(10):2203–11. 10.1007/s10461-016-1409-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rotondi NK, Bauer GR, Scanlon K, Kaay M, Travers R, Travers A. Nonprescribed Hormone Use and Self-Performed Surgeries: “Do-It-Yourself” Transitions in Transgender Communities in Ontario, Canada. Am J Public Health. 2013. October;103(10):1830–6. 10.2105/AJPH.2013.301348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Waite S, Denier N. A Research Note on Canada’s LGBT Data Landscape: Where We Are and What the Future Holds: Canada’s LGBT Data Landscape. Canadian Review of Sociology/Revue canadienne de sociologie. 2019. February;56(1):93–117. 10.1111/cars.12232 [DOI] [PubMed] [Google Scholar]
  • 28.Scheim AI, Bauer GR. Sex and Gender Diversity Among Transgender Persons in Ontario, Canada: Results From a Respondent-Driven Sampling Survey. The Journal of Sex Research. 2015. January 2;52(1):1–14. 10.1080/00224499.2014.893553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Clark BA, Veale JF, Townsend M, Frohard-Dourlent H, Saewyc E. Non-binary youth: Access to gender-affirming primary health care. International Journal of Transgenderism. 2018. April 3;19(2):158–69. [Google Scholar]
  • 30.Wilkinson L, Pearson J, Liu H. Educational attainment of transgender adults: Does the timing of transgender identity milestones matter? Social Science Research. 2018. August;74:146–60. 10.1016/j.ssresearch.2018.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality; 2016. [Google Scholar]
  • 32.Stats Canada. Low income statistics by age, sex and economic family type. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1110013501
  • 33.The GenIUSS Group. Best practices for asking questions to identify transgender and other gender minority respondents on population-based surveys. Herman JL (Ed.). Los Angeles, CA: The Williams Institute. [Google Scholar]
  • 34.Bauer GR. Incorporating intersectionality theory into population health research methodology: Challenges and the potential to advance health equity. Social Science & Medicine. 2014. June;110:10–7. 10.1016/j.socscimed.2014.03.022 [DOI] [PubMed] [Google Scholar]
  • 35.Gonzalez CA, Gallego JD, Bockting WO. Demographic characteristics, components of sexuality and gender, and minority stress and their associations to excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States. J Primary Prevent. 2017. August;38(4):419–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Scheim AI, Bauer GR, Shokoohi M. Drug use among transgender people in Ontario, Canada: Disparities and associations with social exclusion. Addictive Behaviors. 2017. September;72:151–8. 10.1016/j.addbeh.2017.03.022 [DOI] [PubMed] [Google Scholar]
  • 37.Watson RJ, Veale JF, Gordon AR, Clark BA, Saewyc EM. Risk and protective factors for transgender youths’ substance use. Preventive Medicine Reports. 2019. Sep;15:100905 10.1016/j.pmedr.2019.100905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Defreyne J, Motmans J, T’sjoen G. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review. Expert Review of Pharmacoeconomics & Outcomes Research. 2017. November 2;17(6):543–56. 10.1080/14737167.2017.1388164 [DOI] [PubMed] [Google Scholar]
  • 39.Glynn TR, Gamarel KE, Kahler CW, Iwamoto M, Operario D, Nemoto T. The role of gender affirmation in psychological well-being among transgender women. Psychology of Sexual Orientation and Gender Diversity. 2016. September;3(3):336–44. 10.1037/sgd0000171 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

H Jonathon Rendina

22 Oct 2020

PONE-D-20-30194

Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada

PLOS ONE

Dear Dr. Klassen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I sent your manuscript for review to two experts in the field, both of whom agreed there were many positive aspects of the study and the written report. At the same time, reviewers raised several important points that I would invite you to consider before the manuscript can be considered for publication. For all reviewer feedback, please provide a point-by-point response. While many issues raised are more focused on technical changes to the manuscript, some do involve ways of rethinking the analyses and you should carefully consider these and provide a strong response if you elect not to pursue such recommendations.

Please submit your revised manuscript by Dec 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

H. Jonathon Rendina, PhD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please state in your methods section whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB approved the lack of parent or guardian consent.

3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a very informative and well-written paper. I thoroughly enjoyed reading it. Just a few minor suggestions:

1) If possible (word count permitting), could you make it more clear in the abstract that cisgender women were the only potential participants excluded based on gender?

2) In the methods section, could you provide the thresholds/criteria used to determine statistical significance?

3) In the results section, I'm assuming you mean "statistically significant" when you say significant differences?

4) For the adjusted ORs (starting with Table 2) in each health topic area (e.g. mental health, sub use, STIs, etc.), were each of these variables assessed in separate models? Each category has an AOR, but from the methods section it sounds like there were only 5 confounders (so I'm assuming they weren't all in the same model or even topic-based models). So were these 5 confounders used for ALL of these variables of interest? More clarification in the model construction would help.

That's all my comments. Really well-written and well done.

Reviewer #2: General - Terminology:

1. Authors use various terminology to describe sexual minority men. In row 40, I would introduce ‘sexual minority men’ as an umbrella term.

2. Authors use language ‘minoritized’ to describes sexual and gender minority people. Highly recommend the authors modify the language from ‘minoritized’ to ‘minority’, which is consistent with the current literature.

3. I would strongly recommend some additional context for the designation of the ‘non-binary’ group. Authors categorized participants in this group who responded “neither” to the question “What is your gender identity?” with the possible responses being: “man” “woman” or “neither. I prefer to self-describe as: _____________.”

From my reading of the article, authors should define the term ‘non-binary’ and its rationale for use based on the response options provided above. Since ‘non-binary’ is an identity label, it is very possible that participants self-described their identity as non-binary in the open text field. But for those participants who didn’t, it needs to be clear that its use in this article is more of an umbrella term.

Abstract:

Row 32: Please add comparison group (cisgender sexual minority men)

Introduction:

Row 49: Authors provided an example of a healthcare disparity – I would suggest changing the term ‘health disparities’ to ‘healthcare disparities’.

Row 64: Health disparities are introduced here. I would recommend modifying this sentence: “Additionally, trans and non-binary people experience health disparities, and report poorer physical and mental health than their cisgender peers”.

Row 84: Recommend changing “statistics” to “findings”.

Row 84: It is unclear if these findings are associated with the Trans PULSE study or the qualitative interviews conducted by Rich et al.: “Some participants were living in an urban centre and well-connected to healthcare systems, such as routine transition-related care appointments that made integrating HIV testing into their regular healthcare regimen easy”. Please clarify.

Row 98: I would recommend clarifying the time-period for ‘did not have enough to eat’

Row 155: I would recommend moving the social media recruitment efforts earlier in the paragraph with the other recruitment efforts.

Results

Due to the questions about gender identity and trans experience, the authors indicated they are unable to provide statistical comparisons between the those who identified as trans and those who were categorized in the non-binary group and acknowledge this as a limitation. I would suggest that the authors discuss rationale for not using an analysis plan with four categories: (1) cisgender, (2) trans, (3) non-binary, and (4) non-binary with trans experience.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 11;16(2):e0246525. doi: 10.1371/journal.pone.0246525.r002

Author response to Decision Letter 0


9 Dec 2020

(See attached Response to Reviewers document for formatted version)

RESPONSE TO REVIEWERS

Thank you for the opportunity to revise and resubmit this manuscript for consideration in PLOS ONE. We are appreciative of the comments provided by the editor and reviewers, which have strengthened this manuscript. Authors responses are in bullet-points and bolded text below reviewer comments.

We would like to amend our Financial Disclosure statement to the following:

Sex Now 2018 received funding support from Canadian Blood Services MSM Research Fund, funded by the federal government (Health Canada) and the provincial and territorial ministries of health. The views herein do not necessarily reflect the views of Canadian Blood Services or the federal, provincial, or territorial governments of Canada. Additional in-kind contributions were received from the Public Health Agency of Canada's National Microbiology Laboratory. Additional funding for this analysis was provided by Women and Gender Equality (WAGE) Canada. NJL is supported by a Scholar Award from the Michael Smith Foundation for Health Research (#16863).

When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

• We have made changes to the manuscript based on the provided submission guidelines.

Please state in your methods section whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB approved the lack of parent or guardian consent.

• Thank you. We have clarified that no parental consent was required per our REB approval in lines 180 and 181 of the clean manuscript.

We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers.

Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#locrecommended-repositories."

• The University of Victoria's Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to Dr. Nathan Lachowsky at the University of Victoria (nlachowsky@uvic.ca).

Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1.

Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes

• Response Not Applicable

Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes

• Response Not Applicable

Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No

• The University of Victoria's Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to Dr. Nathan Lachowsky at the University of Victoria (nlachowsky@uvic.ca).

Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes

• Response Not Applicable

Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

If possible (word count permitting), could you make it more clear in the abstract that cisgender women were the only potential participants excluded based on gender?

• Line 27 includes a sentence clarifying that all people who identified as women were ineligible

In the methods section, could you provide the thresholds/criteria used to determine statistical significance?

• Thank you. We have added text in the methods section to provide this information in lines 214-215 of the clean manuscript.

In the results section, I'm assuming you mean "statistically significant" when you say significant differences?

• Correct. We have added qualifiers in throughout results to clarify we mean “statistically significant.”

For the adjusted ORs (starting with Table 2) in each health topic area (e.g. mental health, sub use, STIs, etc.), were each of these variables assessed in separate models? Each category has an AOR, but from the methods section it sounds like there were only 5 confounders (so I'm assuming they weren't all in the same model or even topic-based models). So were these 5 confounders used for ALL of these variables of interest? More clarification in the model construction would help. That's all my comments. Really well-written and well done.

• We have added content in lines 212-213 and 290-291 to clarify that each variable was assessed in separate models, and adjusted for the same 5 confounders.

General - Terminology:

Authors use various terminology to describe sexual minority men. In row 40, I would introduce ‘sexual minority men’ as an umbrella term.

• Thank you. We have added the phrase ‘sexual minority’ men and replaced instances of ‘minoritized’ with ‘minority’.

Authors use language ‘minoritized’ to describes sexual and gender minority people. Highly recommend the authors modify the language from ‘minoritized’ to ‘minority’, which is consistent with the current literature.

• See comment directly above.

I would strongly recommend some additional context for the designation of the ‘non-binary’ group. Authors categorized participants in this group who responded “neither” to the question “What is your gender identity?” with the possible responses being: “man” “woman” or “neither. I prefer to self-describe as: _____________.” From my reading of the article, authors should define the term ‘non-binary’ and its rationale for use based on the response options provided above. Since ‘non-binary’ is an identity label, it is very possible that participants self-described their identity as non-binary in the open text field. But for those participants who didn’t, it needs to be clear that its use in this article is more of an umbrella term.

• We have added content in rows 197-200 to give context and rationale for the non-binary group.

Abstract: Row 32: Please add comparison group (cisgender sexual minority men)

• We have added the comparison group.

Introduction: Row 49: Authors provided an example of a healthcare disparity – I would suggest changing the term ‘health disparities’ to ‘healthcare disparities’.

• We have changed the term to healthcare disparities.

Row 64: Health disparities are introduced here. I would recommend modifying this sentence: “Additionally, trans and non- binary people experience health disparities, and report poorer physical and mental health than their cisgender peers”.

• We have edited this sentence as suggested.

Row 84: Recommend changing “statistics” to “findings”. Row 84: It is unclear if these findings are associated with the Trans PULSE study or the qualitative interviews conducted by Rich et al.: “Some participants were living in an urban centre and well-connected to healthcare systems, such as routine transition-related care appointments that made integrating HIV testing into their regular healthcare regimen easy”. Please clarify.

• We have changed ‘statistics’ to ‘findings’ and clarified that findings referenced the Rich et al study.

Row 98: I would recommend clarifying the time-period for ‘did not have enough to eat’

• We have clarified that this was asked for a 12-month period.

Row 155: I would recommend moving the social media recruitment efforts earlier in the paragraph with the other recruitment efforts.

• We have moved this earlier in the paragraph.

Results: Due to the questions about gender identity and trans experience, the authors indicated they are unable to provide statistical comparisons between the those who identified as trans and those who were categorized in the non-binary group and acknowledge this as a limitation. I would suggest that the authors discuss rationale for not using an analysis plan with four categories: (1) cisgender, (2) trans, (3) non-binary, and (4) non-binary with trans experience.

• We have added clarification and rationale for our gender groupings in the results section (lines 577-582 of the clean manuscript).

Attachment

Submitted filename: ResponsetoReviewers.docx

Decision Letter 1

H Jonathon Rendina

21 Jan 2021

Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada

PONE-D-20-30194R1

Dear Dr. Klassen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

H. Jonathon Rendina, PhD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors have thoroughly addressed all comments and have provided a rationale for why the data that underlies the findings described in their manuscript are not fully available without restriction.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

H Jonathon Rendina

26 Jan 2021

PONE-D-20-30194R1

Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada

Dear Dr. Klassen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. H. Jonathon Rendina

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: ResponsetoReviewers.docx

    Data Availability Statement

    Partial Sex Now data is publicly available on the Our Stats dashboard (https://ourstats.ca/our-dashboard). The University of Victoria’s Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to University of Victoria’s Human Research Ethics Board (250-472-4545 or ethics@uvic.ca).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES